This study’s ROC analysis showed that VCAM-1 demonstrated high sensitivity and specificity in predicting an early renal recovery in patients with S-AKI and that CD62E had high sensitivity but low specificity in predicting an early renal recovery in these patients. The gene discussed is VCAM1; the disease is acute kidney injury.